Valproate: survey on awareness of teratogenicity risk and impact of risk minimisation measures in women of childbearing age.

17/04/2026
03/11/2026
EU PAS number:
EUPAS1000000735
Study
Finalised
Documents
Study protocol
Initial protocol
English (664.04 KB - PDF) View document
Updated protocol
English (250.02 KB - PDF) View document
English (683.79 KB - PDF) View document
Study results
No information provided.
Study report
No information provided.
ENCePP Seal
No information provided.